Tag: drug

How You Can Measure A Drug Abuse Treatment

Evaluating substance abuse intervention of addiction centers can be complicated due to the different personalities of individuals involved. Usually, the efficacy of treatment intervention is characterized by a person’s behavior after the intervention but can be undermined due to minimal gains and relapse. Since anything can occur during intervention, families and friends must be ready and be prepared for it.

How can you evaluate treatment intervention? Actually, there are numerous methods of measuring the substance abuse intervention of addiction rehab facility.

Using the baseline of the patient’s behavior before the treatment. Be sure to take note of his or her habits, emotions and behaviors weeks before intervention to evaluate the effectiveness of treatment. Usually, baseline behavior is easy to identify in kids and teens, while adults tend to mask attitudes to hide drug addiction.

During the intervention period, be sure to observe the patient’s non-verbal and verbal response to treatment. Is the patient dedicated to the therapy program? Is he or she trying to escape with confrontation? Since behavioral responses vary according to the age level of patients, be sure to inquire from experts, counselors, health worker, therapists and religious leader about it. Keep in mind that some of them are good in hiding and denying their utilization of illegal substances.

Pay attention to their behaviors before and after the therapy intervention. Take note of changes on their behaviors, attitudes, and signs of reduced use or discontinued utilization of illegal substances. Changes manifested on patients will identify how effective the therapy intervention is. Since withdrawal symptoms vary according to the prohibited substances used, be sure to inquire and to consult experts on how to handle them and how to notice signs of drug and alcohol abuse. Because drug abuse relapse can happen anytime, patient monitoring is important.

Give support after treatment intervention. Ask him or her on the things he or she wants to make him or her sober and clean. You can also enlist him in drug and alcohol abuse counseling to educate her or him about the harmful consequences of drug abuse. Since the first period of intervention is tough, have someone to observe and to watch over the patient.

Because alcohol and drug abuse are dangerous to the lives of patients and to the individuals around them, be sure to admit them in reputable rehab centers. Be observant and patient in examining the efficacy of drug and alcohol abuse intervention to ensure complete recovery of patients.

Leave a Comment

Drug Patents Are Good For Our Health

Miles White, Chairman and CEO of Abbott Laboratories recently wrote about the importance of drug patents for the future of medicine. He began by talking about a case settled by Abbott and the South American country of Brazil. Brazil felt that the price of Abbotts AIDS medication Kaletra, the most widely used AIDS medication, was too high and patients could not afford it. They were threatening to break Abbotts patent and produce a generic version locally in order to treat more patients. The two sides reached an agreement as Abbott agreed to significantly reduce the price per patient and the government agreed to honor the patent.

White points out that while this situation ended well for both parties involved, this issue should not be forgotten. He writes, we cannot let the agreement end discussion of the ideas involved; it is essential that we consider their implications so as to avoid situations that might not be so fortunately resolved. What hangs in the balance is how the world will continue to develop the medicines it needs.

He also writes about the need for a balance to exist between innovation and access to medicine:

The negotiation raised a well-worn chorus of criticisms of the patent system, but failed to address the underlying question: how would our society continue to progress without it? The problem is that our global needs and global systems are in conflict. This threatens to harm one goal, innovation, in the name of another, access to medicine. Access is the goal the world cares about and one taken seriously by innovator companies (those that conduct research and development of new medicines) that have made significant contributions to this end across the developing world – from building healthcare infrastructure in Africa, to drastic price cuts that have benefited a wide range of countries, including Brazil. But it must be recognized that access is inseparable from innovation: without access, innovation is meaningless; without innovation, there is nothing to have access to.

White concludes by quoting President Abraham Lincoln, The patent system added the fuel of interest to the fire of genius. The patent system exists so that innovation can continue. So scientists discoveries are protected.

Leave a Comment

Bladder Cancer – Global Drug Forecasts And Treatment Analysis To 2020 – Volume 1 2011

GlobalData analysis finds that the global bladder cancer therapeutics market is moderately attractive and is primarily driven by growth in the patient volume and growth in the cost of therapy. The patient volume was driven by growth in treatment usage pattern measurements such as diseased population, treatment seeking population, Diagnosed Population and prescription population.

In 2010, the bladder cancer therapeutics markets key markets (the US, UK, Germany, France, Italy, Spain, Japan, Brazil, Russia, India and China) were collectively worth $610m. The markets size is driven by two key parameters, namely the patient volume and the annual cost of therapy per patient. Between 2001 and 2010, the global bladder cancer therapeutics market grew at a CAGR of 8.0%.

For Sample Pages, please click or add the below link to your browser:

The bladder cancer therapeutics market is completely dominated by generic drugs such as methotrexate, cisplatin, vinblastin and doxorubicin. BCG (Bacillus Calmette-Gurin) therapy and mitomycin C are the other drugs that are used for the treatment of bladder cancer.

Gemcitabine was the top-selling drug in the bladder cancer therapeutics market in 2010. The other leading drugs in the market in 2001 were BCG therapy and methotrexate which registered sales of $55m and $57m. In 2010, gemcitabine was the leading drug in the bladder cancer therapeutics market, with sales of $170m. Methotrexate and BCG therapy were the other leading therapies with sales of $145m and $131m. Between 2010 and 2020, three promising therapies, Javlor (vinflunine), Urocidin (intravesical formulation of Mycobacterial cell wall-DNA complex (MCC)) and EOquin (apaziquone), are expected to hit the market. Between 2010 and 2020, the market is expected to be led by Urocidin, with forecast sales of $386m.

GlobalData, the industry analysis specialist, has released its new report, Bladder Cancer – Global Drug Forecasts and Treatment Analysis to 2020 Volume 1 2011. The report is an essential source of information and analysis on the global bladder cancer therapeutics market. The report provides comprehensive information on bladder cancer, highlighting the treatment guidelines. It identifies and analyses the key trends shaping and driving the global bladder cancer therapeutics market. It analyses the treatment usage patterns in the global bladder cancer therapeutics market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. The report provides valuable insights into the pipeline products within the global bladder cancer sector. It quantifies the unmet need in the global bladder cancer therapeutics market as well as in the individual markets such as the US and the top five countries in Europe, highlighting the opportunity for future players.

For further details, please click or add the below link to your browser:

Visit our report store:

For more details contact:
[email protected]
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782

Leave a Comment